CAPA – Page 12 – Pharma.Tips

Deviation Handling for DSCSA data gaps in Serialization & Track-and-Trace

Effective Strategies for Addressing DSCSA Data Gaps in Serialization and Track-and-Trace In the pharmaceutical industry, the capability to accurately serialize products is critical for compliance with regulations, such as the…

How QA Should Review Serialization & Track-and-Trace Before Batch Release

Best Practices for QA Review of Serialization and Track-and-Trace Protocols Pre-Batch Release The complexities of serialization and track-and-trace in pharmaceutical manufacturing are critical for compliance with regulations such as DSCSA…

Training Gaps That Cause serialization reconciliation errors in Serialization & Track-and-Trace

Identifying and Resolving Training Deficiencies Leading to Serialization Reconciliation Errors Serialization and track-and-trace processes are critical in today’s pharmaceutical industry, ensuring compliance with regulations such as DSCSA in the U.S.…

How to Trend and Review serial number duplication in Serialization & Track-and-Trace

Addressing Serial Number Duplication Issues in Serialization and Track-and-Trace Systems In the ever-evolving pharmaceutical landscape, ensuring the integrity of serialization and track-and-trace systems is paramount. Serial number duplication poses significant…

Data Integrity Risks in Serialization & Track-and-Trace Records

Case Study: Navigating Data Integrity Risks in Serialization and Track-and-Trace Records The pharmaceutical industry continues to face considerable challenges regarding data integrity in serialization and track-and-trace records. Non-compliance not only…

Practical SOP Controls for Serialization & Track-and-Trace

Effective Solutions for Managing Serialization and Track-and-Trace Issues In the pharmaceutical industry, proper serialization and track-and-trace systems are crucial for compliance with regulations such as the Drug Supply Chain Security…

Top Mistakes in Serialization & Track-and-Trace and How to Avoid Them

Avoiding Common Mistakes in Serialization and Track-and-Trace Processes The regulatory landscape for pharmaceutical serialization and track-and-trace systems presents significant challenges for manufacturers and distributors. Mistakes in this area can lead…

How to Build a Risk-Based Control Strategy for Serialization & Track-and-Trace

Developing a Risk-Based Control Strategy for Serialization and Track-and-Trace in Pharmaceuticals The pharmaceutical industry faces increasing challenges in ensuring compliance with serialization and track-and-trace regulations such as the DSCSA in…

Regulatory Expectations for Serialization & Track-and-Trace: What QA Must Verify

Understanding Regulatory Requirements for Serialization and Track-and-Trace in Pharmaceuticals As the pharmaceutical industry evolves, ensuring compliance with serialization track and trace requirements has become both a regulatory necessity and a…

Best Practices for Managing EU FMD alert handling issues in Serialization & Track-and-Trace

Managing EU FMD Alert Handling Issues in Serialization and Track-and-Trace: A Case Study The pharmaceutical industry has seen increased scrutiny regarding serialization and track-and-trace initiatives, particularly in light of compliance…

Audit Findings Linked to DSCSA data gaps in Serialization & Track-and-Trace

Addressing Audit Findings Related to Gaps in Serialization and Track-and-Trace Data In today’s pharmaceutical landscape, the integrity of the supply chain is paramount. Audit findings related to serialization and track-and-trace…

CAPA Strategy for aggregation failures in Serialization & Track-and-Trace

Implementing a CAPA Strategy to Address Aggregation Failures in Track-and-Trace Systems In the pharmaceutical sector, aggregation failures in serialization and track-and-trace systems are not just a nuisance; they can lead…